GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Semler Scientific Inc.
Semler Scientific produces a diagnostic device for detecting peripheral artery disease. Its stock price reflects the success of its model, which leases devices to doctors for recurring revenue. A recent decision to invest in Bitcoin has added to the volatility.
Share prices of companies in the market segment - Diagnostic medical equipment
Semler Scientific develops and markets patented products that help physicians diagnose and treat chronic conditions, particularly peripheral arterial disease. We classify it as "Diagnostic Medical Equipment." The chart below shows the dynamics of this technologically advanced medical sector.
Broad Market Index - GURU.Markets
Semler Scientific is a medical device company that develops and markets diagnostic products for chronic diseases, particularly peripheral artery disease. As a significant player, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Semler's performance to assess the state of the sector.
Change in the price of a company, segment, and market as a whole per day
SMLR - Daily change in the company's share price Semler Scientific Inc.
The volatility of Semler Scientific, a developer of vascular diagnostic tests, reflects the state of the medical technology sector. Change_co measures sensitivity to product news and changes in health insurance. This metric is key to analyzing the diagnostic equipment sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Diagnostic medical equipment
Semler Scientific, Inc. is a medical diagnostics company. This chart shows high volatility. Comparing it to SMLR, whose success depends on the introduction of its vascular diagnostic tests, helps assess its unique risks.
Daily change in the price of a broad market stock, index - GURU.Markets
Semler is a company that has developed a test for the early detection of peripheral artery disease. The medical technology market is growing rapidly. The chart below shows the volatility in this sector, helping to assess how Semler shares are responding to innovation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Semler Scientific Inc.
Semler Scientific's year-over-year performance is a story about the introduction of its diagnostic test for peripheral artery disease. The company's market capitalization growth over the past 12 months is directly linked to the growing number of doctors and clinics leasing its QuantaFlo device, providing the company with a stable and predictable stream of high-margin revenue.
Annual dynamics of market capitalization of the market segment - Diagnostic medical equipment
Semler Scientific, Inc. produces diagnostic equipment for detecting peripheral artery disease. The company recently took a bold step by investing in Bitcoin. The chart below shows how the market is reacting to this highly unusual strategy, which combines the medical business with cryptocurrency speculation.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Semler, with its diagnostic equipment, has made an unexpected turn by making Bitcoin its primary reserve asset. Its stock performance is now a hybrid. The chart reflects not only the success of its medical business but also, to a greater extent, the volatility and sentiment of the cryptocurrency market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Semler Scientific Inc.
Semler Scientific's price reflects two factors: the growth of its medical business and its new Bitcoin strategy. Monthly fluctuations on the chart depend on sales of its QuantaFlo diagnostic system, and now also strongly correlate with the volatile price of Bitcoin, which the company has begun actively buying.
Monthly dynamics of market capitalization of the market segment - Diagnostic medical equipment
Semler Scientific develops and markets diagnostic products that help detect chronic diseases, particularly peripheral artery disease. The company has also invested in Bitcoin as a reserve asset. The chart below shows the dynamics of the medical device sector, where Semler occupies a unique niche.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Semler Scientific develops technologies for vascular disease diagnostics. As a medical technology company, its shares can move independently of the market, responding to clinical successes, regulatory approvals, and the pace of product adoption. The chart will show whether the company is following the trends of medical innovation or is subject to general investment sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Semler Scientific Inc.
Semler Scientific develops diagnostic tests for peripheral artery disease. Its weekly stock price reflects data on physician use of its technology and changes in the Medicare reimbursement system. The chart shows how the market views diagnostic innovations.
Weekly dynamics of market capitalization of the market segment - Diagnostic medical equipment
Semler Scientific, like the entire diagnostic equipment sector, is responding to industry-wide news regarding Medicare reimbursement and the pace of new technology adoption in clinics. The chart below shows how the company is performing in the context of these industry factors.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Semler Scientific develops diagnostic tests. As a healthcare company, it should be less dependent on the economy. The chart will show how insulated its shares are from market fluctuations, moving in sync with product news rather than under the influence of general macroeconomic data.
Market capitalization of the company, segment and market as a whole
SMLR - Market capitalization of the company Semler Scientific Inc.
The chart for Semler Scientific, Inc. tells the story of the introduction of a new technology into medical diagnostics. Its market capitalization reflects how the market perceives demand for a device for the early detection of peripheral artery disease. This dynamic represents the battle between innovation and established practices.
SMLR - Share of the company's market capitalization Semler Scientific Inc. within the market segment - Diagnostic medical equipment
Semler Scientific, Inc. captures its market share by providing diagnostic equipment for detecting peripheral arterial disease. Its market capitalization reflects its business model, which licenses rather than sells its devices, generating recurring revenue.
Market capitalization of the market segment - Diagnostic medical equipment
Semler Scientific offers diagnostic solutions for chronic disease detection. What is the size of this industry? The chart below shows the overall market capitalization of the diagnostic equipment sector. Its steady growth reflects the importance of early diagnosis in reducing healthcare costs.
Market capitalization of all companies included in a broad market index - GURU.Markets
The Semler Scientific chart visualizes how innovative diagnostics are changing treatment approaches. The market capitalization of the company, whose product helps detect peripheral artery disease, depends on the rate of its adoption in clinics. This diagram shows how improved diagnostics generates market value.
Book value capitalization of the company, segment and market as a whole
SMLR - Book value capitalization of the company Semler Scientific Inc.
Semler Scientific's assets include its production lines for creating diagnostic equipment for vascular diseases, as well as its R&D infrastructure. Its book value reflects the value of these high-tech assets. The chart below shows how the company has invested in its production capital.
SMLR - Share of the company's book capitalization Semler Scientific Inc. within the market segment - Diagnostic medical equipment
Semler Scientific creates early diagnostic technologies, and its business has a physical foundation. These are the production lines used to assemble its flagship product, QuantaFlo, a device for detecting arterial disease. The chart shows the company's control over this niche but crucial medical manufacturing infrastructure.
Market segment balance sheet capitalization - Diagnostic medical equipment
Semler Scientific is a medical diagnostics company. In a capital-intensive industry, its model is "asset-light." The industry's asset chart reflects the value of its plants. Semler, on the other hand, doesn't manufacture complex equipment; it licenses its software.
Book value of all companies included in the broad market index - GURU.Markets
Semler Scientific's balance sheet includes not only patents but also manufacturing capacity for creating diagnostic devices that help detect vascular diseases. The chart below shows how the company's resources for manufacturing its medical devices have grown.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Semler Scientific Inc.
Semler Scientific's assets are their diagnostic instruments. But the market pays a huge premium for their business model, which relies on leasing these instruments, generating a stable income. The chart below shows how the market valued this model.
Market to book capitalization ratio in a market segment - Diagnostic medical equipment
Semler Scientific develops diagnostic products for chronic disease detection. Its value lies in its unique technology and its potential for dissemination. The chart shows the market premium it places on its innovation and business model over the value of its tangible assets.
Market to book capitalization ratio for the market as a whole
Semler Scientific develops diagnostic products for chronic disease detection. Its flagship product helps detect peripheral artery disease. Unlike the average valuation on this chart, its market capitalization is built on the uniqueness of its technology and a sales model that generates recurring revenue from each test.
Debts of the company, segment and market as a whole
SMLR - Company debts Semler Scientific Inc.
Semler Scientific develops diagnostic products for chronic diseases. This chart shows how the company finances its growth. Low debt and high profitability demonstrate the success of its core business model, which relies on technology licensing to generate strong cash flow.
Market segment debts - Diagnostic medical equipment
Semler Scientific develops and markets diagnostic products to help detect chronic diseases, particularly peripheral artery disease. The company recently diversified its strategy by investing in Bitcoin. This chart illustrates how its leverage reflects this new, unusual capital management strategy for a healthcare company.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Semler Scientific Inc.
Semler Scientific develops and markets diagnostic equipment for chronic diseases. This chart shows the company's reliance on debt to fund its research, production, and marketing. For investors, this indicates the company's financial independence and the risks associated with bringing new medical technologies to market.
Market segment debt to market segment book capitalization - Diagnostic medical equipment
Semler Scientific develops products for chronic disease diagnostics. This chart shows the debt burden in the medical diagnostics sector. It helps understand how companies in this niche finance their research and product commercialization, and how Semler Scientific, with its focus on peripheral arterial disease, compares against this backdrop.
Debt to book value of all companies in the market
Semler Scientific develops diagnostic equipment. The company's growth depends on investments in new technologies and marketing for their implementation in clinics. This chart shows the market's overall risk appetite through the use of debt. It provides insight into whether Semler is financing its innovations with debt, in line with overall technology trends.
P/E of the company, segment and market as a whole
P/E - Semler Scientific Inc.
Semler Scientific develops diagnostic products for chronic diseases, particularly peripheral artery disease. The company recently took a bold step by investing in Bitcoin. This chart reflects the mixed sentiment among investors: on the one hand, the company's medical business, and on the other, a corporate Bitcoin strategy like MicroStrategy's.
P/E of the market segment - Diagnostic medical equipment
Semler Scientific develops and markets diagnostic products that help detect chronic diseases. Their flagship product, QuantaFlo, is used for the rapid diagnosis of peripheral artery disease. This chart shows the overall rating for the diagnostic equipment sector, reflecting the market's appreciation for technologies that enable early diagnosis.
P/E of the market as a whole
Semler Scientific develops and markets diagnostic products for chronic diseases. Its core product helps detect peripheral artery disease. The company recently bet on Bitcoin, which has radically changed its profile. Its valuation is now a hybrid of a healthcare business and a crypto asset, making its performance unpredictable compared to overall market trends.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Semler Scientific Inc.
Semler Scientific develops and markets products for vascular disease diagnostics. Its key product, QuantaFlo, helps detect peripheral arterial disease. This graph reflects expectations for the adoption of its technology in clinical practice. The company's valuation depends on sales forecasts for its diagnostic systems to clinics and hospitals.
%20P%2FE%20Semler%20Scientific%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Semler-Scientific-Inc.&v=1772513695302 "Chart of the company's future (projected) P/E Semler Scientific Inc.")
Future (projected) P/E of the market segment - Diagnostic medical equipment
Semler Scientific develops products for cardiovascular diagnostics. The company recently made a bold move by investing a significant portion of its reserves in Bitcoin. This chart reflects the market's view of this dual nature. It compares its profit expectations to the sector, but also takes into account its new cryptocurrency strategy.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Diagnostic-medical-equipment&v=1772513695318 "Future (projected) P/E graph of the market segment - Diagnostic medical equipment")
Future (projected) P/E of the market as a whole
Semler Scientific develops and markets diagnostic products for chronic disease detection. The company operates at the intersection of healthcare and technology. This graph of overall market sentiment is less important to the company than demographic trends, such as an aging population, and healthcare regulatory decisions, which drive robust demand.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513695365 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Semler Scientific Inc.
Semler Scientific, Inc. develops and markets diagnostic products for chronic disease detection. Its key product helps detect peripheral arterial disease. The company's revenue depends on the number of physicians and clinics using its equipment. This chart shows how the adoption of medical technology impacts financial performance.
Profit of companies in the market segment - Diagnostic medical equipment
Semler Scientific develops and markets diagnostic products for the detection of chronic diseases, particularly peripheral arterial disease. The company's success depends on the implementation of its technologies in clinical practice. This chart shows overall revenue in the diagnostic equipment sector, reflecting trends in healthcare spending and the adoption of innovative solutions.
Overall market profit
Semler Scientific develops and markets diagnostic equipment for the detection of chronic diseases, particularly peripheral arterial disease. Demand for its products is driven by the need for early diagnosis to reduce healthcare costs. The company's success contributes to the medical technology sector, an important and growing segment of the economy.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Semler Scientific Inc.
Semler Scientific develops diagnostic devices for chronic diseases, particularly peripheral artery disease. This chart shows expectations for expanded use of its QuantaFlo technology. Revenue depends on the number of tests performed by physicians and reimbursement from insurance companies.
%20profit%20of%20the%20company%20Semler%20Scientific%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Semler-Scientific-Inc.&v=1772513695672 "Graph of future (projected) profit of the company Semler Scientific Inc.")
Future (predicted) profit of companies in the market segment - Diagnostic medical equipment
Semler Scientific develops and markets diagnostic products for the detection of chronic diseases, particularly peripheral arterial disease. The data in the chart shows revenue projections for the medical device sector. This allows us to assess how the company's focus on early diagnosis and prevention impacts the market potential of its products.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Diagnostic-medical-equipment&v=1772513695676 "Graph of future (predicted) profits of companies in a market segment - Diagnostic medical equipment")
Future (predicted) profit of the market as a whole
The dynamics in this chart reflect expectations for a company that produces diagnostic equipment for detecting peripheral artery disease. Semler Scientific's profit outlook depends on the widespread adoption of its QuantaFlo technology in medical practice. A recent Bitcoin investment strategy adds a new, unrelated volatility factor.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513695679 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Semler Scientific Inc.
Semler Scientific develops diagnostic products, and its revenue is directly dependent on their adoption in medical practice. This chart shows how investors assess its sales growth potential. The multiple reflects the market's confidence that its technologies will become standard in their niche and generate stable revenue.
P/S market segment - Diagnostic medical equipment
Semler Scientific develops and markets diagnostic products for the detection of chronic diseases, particularly peripheral arterial disease. Revenue comes from the sale and licensing of equipment. This chart shows the average valuation in the medical diagnostic equipment sector, helping to understand how the market values the contribution of Semler's technologies to the company's revenue.
P/S of the market as a whole
Semler Scientific develops and markets diagnostic products for chronic diseases, particularly peripheral arterial disease. Its revenue depends on the adoption of its technology in clinical practice. This graph, which displays average revenue estimates, helps Semler understand the market premium for innovative medical technologies that can reduce costs.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Semler Scientific Inc.
Semler Scientific develops products for diagnosing peripheral arterial disease. The company recently took a bold step by investing in Bitcoin as a reserve asset. This chart shows how the market views its future revenue, which now depends not only on medical equipment sales but also on the price of the leading cryptocurrency.
%20P%2FS%20Semler%20Scientific%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Semler-Scientific-Inc.&v=1772513695771 "The graph of the company's future (projected) P/S Semler Scientific Inc.")
Future (projected) P/S of the market segment - Diagnostic medical equipment
Semler Scientific develops and markets diagnostic products for cardiovascular risk assessment. This chart compares the company's estimated future sales with other diagnostic equipment manufacturers. It reflects investor expectations for the introduction of its flagship product, QuantaFlo, for detecting peripheral artery disease.
%20P%2FS%20market%20segment%20graph%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Diagnostic-medical-equipment&v=1772513695799 "Future (projected) P/S market segment graph - Diagnostic medical equipment")
Future (projected) P/S of the market as a whole
Semler Scientific develops diagnostic devices for detecting peripheral arterial disease. Demand for its products is driven by the implementation of new healthcare standards and physician awareness. The company's revenue growth reflects the trend toward early diagnosis, which helps reduce overall treatment costs over the long term.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513695835 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Semler Scientific Inc.
Semler Scientific develops and markets diagnostic equipment that helps detect chronic diseases, particularly peripheral artery disease. This chart reflects revenue from the sale or lease of its devices to medical institutions. This growth reflects the adoption of its technology in clinical practice.
Sales of companies in the market segment - Diagnostic medical equipment
Semler Scientific develops and markets diagnostic products that help detect chronic diseases, particularly peripheral artery disease. Its technology enables testing to be performed quickly and in the doctor's office. This chart shows overall sales in the medical equipment market, illustrating the demand for innovative and affordable diagnostic solutions.
Overall market sales
Semler Scientific develops and markets diagnostic products for the detection of chronic diseases, particularly peripheral artery disease. This economic growth impacts Semler through healthcare budgets. Economic growth allows healthcare institutions to invest in new diagnostic equipment for the early detection of diseases.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Semler Scientific Inc.
Semler Scientific develops and markets diagnostic products to help detect chronic diseases, particularly peripheral artery disease. The company's future revenue depends on the adoption of its technologies in clinical practice. This chart reflects analysts' forecasts for demand for innovative and cost-effective early diagnostic methods.
%20sales%20of%20the%20company%20Semler%20Scientific%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Semler-Scientific-Inc.&v=1772513695899 "Schedule of future (projected) sales of the company Semler Scientific Inc.")
Future (projected) sales of companies in the market segment - Diagnostic medical equipment
Semler Scientific develops and markets products for the diagnosis of peripheral arterial disease. This chart shows projected revenue for the entire diagnostic equipment sector. It reflects expectations for rising healthcare costs and the adoption of new diagnostic technologies, which are important for the growth of Semler's products.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Diagnostic-medical-equipment&v=1772513695900 "Schedule of future (projected) sales of companies in the market segment - Diagnostic medical equipment")
Future (projected) sales of the market as a whole
Semler Scientific develops medical technologies for diagnosing peripheral arterial disease. Demand for its products depends on healthcare budgets and the growing awareness of the importance of early detection. This dynamic, reflecting the state of the economy, influences healthcare funding. Economic stability allows clinics to invest in new diagnostic equipment like that offered by Semler.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513695926 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Semler Scientific Inc.
Semler Scientific develops and sells diagnostic equipment for chronic diseases. This chart shows the profitability of its business model, which relies on the sale or leasing of medical devices. This metric reflects the balance between production and R&D costs and revenue from clinics seeking to improve diagnostic quality.
Market segment marginality - Diagnostic medical equipment
Semler Scientific develops and markets diagnostic products for chronic disease detection. Its flagship product facilitates the early detection of peripheral arterial disease. This chart demonstrates the company's high operational efficiency, reflecting the uniqueness of its technology, its strong market position, and its ability to command a high margin.
Market marginality as a whole
Semler Scientific develops diagnostic tests for chronic diseases. The company's success depends on the implementation of its technologies in clinics. The total market return chart shows how such healthcare innovations create value independent of general economic cycles, as they solve critical medical problems and improve patients' quality of life.
Employees in the company, segment and market as a whole
Number of employees in the company Semler Scientific Inc.
Semler Scientific develops and markets diagnostic products for chronic disease detection. This graph shows a focused team promoting its technologies to physicians. The growth in staff is directly related to the expansion of commercial efforts to introduce their products into clinical practice and the development of new diagnostic tests.
Share of the company's employees Semler Scientific Inc. within the market segment - Diagnostic medical equipment
This indicator demonstrates how Semler Scientific is committed to improving diagnostics. The company's medical device division is focused on developing and selling products for detecting peripheral arterial disease. This team created a noninvasive test that allows doctors to detect circulatory problems in patients at an early stage.
Number of employees in the market segment - Diagnostic medical equipment
Semler Scientific develops diagnostic products for the detection of chronic diseases, particularly peripheral arterial disease. The company helps physicians conduct early diagnostics, which requires a team of engineers and clinical specialists. This chart illustrates the growth of the medical device market, where innovations are aimed at prevention and improving quality of life.
Number of employees in the market as a whole
Semler Scientific, Inc. develops products for vascular disease diagnostics. Its business is driven by the healthcare system's need for early diagnosis, not by the economic cycles shown in this chart. The company helps reduce long-term treatment costs, which is valuable in any economic environment.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Semler Scientific Inc. (SMLR)
Semler Scientific develops diagnostic devices for detecting peripheral artery disease. This chart shows how the market values its niche product. The high market capitalization per employee suggests the company can manufacture and market its proprietary equipment with a relatively small team, creating high added value.
%20of%20the%20company%20Semler%20Scientific%20Inc.%20(SMLR)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Semler-Scientific-Inc.-SMLR&v=1772513696043 "Chart of market capitalization per employee (in thousands of dollars) of the company Semler Scientific Inc. (SMLR)")
Market capitalization per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment
Semler Scientific develops diagnostic technologies for detecting chronic diseases. Market capitalization per employee reflects the value of its unique technology and its market potential. A high value may indicate that the company's product addresses an important medical need with high efficiency.
%20by%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Diagnostic-medical-equipment&v=1772513696062 "Market capitalization per employee (in thousands of dollars) by market segment - Diagnostic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Semler Scientific, Inc. develops and markets diagnostic products for chronic disease detection. This chart shows a high cost per employee, typical for the medtech sector. The company focuses on selling its proprietary technology, allowing it to achieve high margins and requiring little staff for production.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513696078 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Semler Scientific Inc. (SMLR)
Semler Scientific (SMLR) is a medical technology company. Their flagship product (QuantaFlo) enables rapid diagnosis of peripheral artery disease (PAD). The company has also recently begun actively buying Bitcoin. This chart shows the performance of their core medical technology business, but it is now "noisy" due to the volatility of crypto assets.
%20Chart%20Semler%20Scientific%20Inc.%20(SMLR)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Semler-Scientific-Inc.-SMLR&v=1772513696113 "Company Profit Per Employee (in thousands of dollars) Chart Semler Scientific Inc. (SMLR)")
Profit per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment
Semler Scientific develops and markets diagnostic products that help detect chronic conditions, such as peripheral artery disease. It's a high-tech medical device company. This chart shows how effectively Semler's team (R&D, sales) creates and monetizes its devices. It reflects the industry average, which serves as a benchmark for assessing the competitiveness of their technologies.
%20in%20the%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Diagnostic-medical-equipment&v=1772513696117 "Chart of profit per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Semler Scientific (SMLR) develops and markets diagnostic products, including QuantaFlo for detecting peripheral arterial disease. It's a medical device business focused on high margins. This chart shows the demand for their patented product. High profit per employee means the company is successfully selling its solution to clinics, and the costs of its small R&D and sales staff are offset.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513696140 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Semler Scientific Inc. (SMLR)
Semler Scientific develops and markets diagnostic products for chronic disease detection. This chart demonstrates the efficiency of its equipment leasing model. Regular payments from clinics ensure stable revenue and high revenue per employee engaged in development and support.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Semler-Scientific-Inc.-SMLR&v=1772513696144 "Sales chart per company employee Semler Scientific Inc. (SMLR)")
Sales per employee in the market segment - Diagnostic medical equipment
Semler Scientific develops and markets diagnostic products, including QuantaFlo for detecting peripheral arterial disease. This chart shows the average revenue per employee in this segment. It helps assess how productive their sales team is in promoting this niche medical device compared to competitors in the medical device sector.
Sales per employee for the market as a whole
Semler Scientific develops and markets diagnostic products, primarily the QuantaFlo, a system for the rapid diagnosis of peripheral arterial disease. It is a high-margin medical device. This chart shows how their small staff (R&D and sales) generates revenue by selling or leasing these innovative devices to clinics.
Short shares by company, segment and market as a whole
Shares shorted by company Semler Scientific Inc. (SMLR)
Semler Scientific is renowned for its QuantaFlo device for the early detection of peripheral artery disease. Recently, the company made a sharp turn by investing in Bitcoin. This chart shows the bets of those who consider this strategy insane. The bears are betting on a decline in BTC and believe the company's core medical business is stagnating.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Semler-Scientific-Inc.-SMLR&v=1772513696254 "Short Shares Chart for the Company Semler Scientific Inc. (SMLR)")
Shares shorted by market segment - Diagnostic medical equipment
Semler Scientific is known for its QuantaFlo diagnostic test, which helps detect peripheral artery disease (PAD) in the doctor's office. This chart shows the overall sentiment in the sector. It reflects investor concerns about changes in the Medicare reimbursement system or a slowdown in the adoption of new diagnostic technologies in clinics.
Shares shorted by the overall market
Semler Scientific (SMLR) produces a diagnostic device for detecting peripheral artery disease. It's an important medical device. But when this chart shows rising fears, investors worry that during a recession, clinics and hospitals (especially smaller ones) will cut back on purchasing new, albeit useful, diagnostic equipment.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Semler Scientific Inc. (SMLR)
Semler Scientific (SMLR) is a company providing diagnostic solutions for healthcare. Their flagship product (QuantaFlo) is a rapid test for peripheral artery disease (PAD). This chart measures hype. It shows "overheated" (above 70) due to rapid adoption of their tests or "oversold" (below 30) due to concerns about competition or reimbursement changes.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Semler-Scientific-Inc.-SMLR&v=1772513696322 "RSI 14 indicator chart for the company's stock Semler Scientific Inc. (SMLR)")
RSI 14 Market Segment - Diagnostic medical equipment
Semler Scientific (SMLR) produced the QuantaFlo diagnostic device for detecting arterial disease. The company recently shifted its strategy and began actively buying Bitcoin. This chart measures the pulse of the Medical Equipment sector, but SMLR's performance now resembles that of a crypto asset. The chart helps us understand how far SMLR has deviated from its "old" sector.
RSI 14 for the overall market
Semler Scientific (SMLR) produces diagnostic equipment. This chart shows that its business is "defensive." Demand for its products isn't driven by euphoria or panic—it's driven by the need for diagnostics. During times of market panic, investors seek safe havens in companies with non-cyclical demand.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast SMLR (Semler Scientific Inc.)
Semler Scientific (SMLR) is a medical technology company. Its flagship product, QuantaFlo, is a rapid, noninvasive test for diagnosing peripheral artery disease (PAD). This chart shows the average 12-month Wall Street forecast. It reflects analysts' estimates of physician adoption and insurance reimbursement rates.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-SMLR-Semler-Scientific-Inc.&v=1772513696427 "A chart showing analyst consensus forecasts for the expected stock price. SMLR (Semler Scientific Inc.)")
The difference between the consensus estimate and the actual stock price SMLR (Semler Scientific Inc.)
Semler Scientific (SMLR) produces the QuantaFlo diagnostic device for detecting peripheral artery disease (PAD) in the doctor's office. They recently shocked the market by buying Bitcoin. This chart shows the valuation of that move. It measures the gap between the price and the consensus target, reflecting analysts' assessment of their medtech business and crypto strategy.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-SMLR-Semler-Scientific-Inc.&v=1772513696483 "A chart showing the difference between the consensus forecast and the actual stock price. SMLR (Semler Scientific Inc.)")
Analyst consensus forecast for stock prices by market segment - Diagnostic medical equipment
Semler Scientific is a unique company. Its core business is diagnostic equipment (QuantaFlo) for detecting arterial disease. However, like MicroStrategy, it recently bet on Bitcoin as a primary treasury asset. This chart shows analyst expectations for the medical device sector, but investors are now viewing Semler through the lens of the crypto sector.
Analysts' consensus forecast for the overall market share price
Semler Scientific (SMLR) is known for its QuantaFlo product, a rapid test for detecting peripheral artery disease (PAD). The company recently shocked the market by buying up Bitcoin. This chart shows overall risk appetite. For SMLR, whose business has dramatically shifted focus, overall optimism (risk appetite) is important, as it supports speculative bets like the one the company has made.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Semler Scientific Inc.
Semler Scientific (SMLR) is a dual-use company. Their legacy is QuantaFlo, a diagnostic device for peripheral artery disease (PAD). Their new strategy is MicroStrategy 2.0: they use their cash flow to aggressively buy Bitcoin. This chart is a hybrid. It balances their (now marginal) medtech business with their new, dominant role as a Bitcoin proxy.
AKIMA Market Segment Index - Diagnostic medical equipment
Semler Scientific (SMLR) is a medtech innovator that (until recently) focused on a single product (QuantaFlo) – a rapid arterial disease (AD) test. The company recently shocked the market by announcing a Bitcoin buying strategy. This composite metric evaluates companies. The chart shows the sector average. This benchmark: how does this dual (medtech + Bitcoin) strategy (SMLR) differentiate it from the average competitor?
The AKIM Index for the overall market
Semler Scientific is a medtech company that produces and markets QuantaFlo, a test for diagnosing peripheral artery disease. This chart, which reflects the market average, provides context. It helps assess how this niche growth story, dependent on physician and insurer adoption, compares to overall economic trends.
